Referências
Pécoul B, Chirac P, Trouiller P, Pinel J. Access to essential drugs in poor countries: a lost battle? JAMA. 281: 361-7, 1999.
Croft, S.L., Seifert, K., Yardley, V. Current scenario of drug development for leishmaniasis. Indian J. Med. Res. 123:399-410, 2006.
Tempone A.G., Sartorelli, P., Mady, C., Fernandes, F. Natural products to anti-trypanosomal drugs: an overview of new drug prototypes for American Trypanosomiasis. Cardiovasc. Hematol. Agents Med. Chem. 5: 222-35, 2007.
Tempone A.G., Pimenta, D.C., Lebrun, I., Sartorelli P., Taniwaki, N.N., de Andrade H.F. Jr., Antoniazzi, M.M., Jared, C. Antileishmanial and antitrypanosomal activity of bufadienolides isolated from the toad Rhinella jimi parotoid macrogland secretion. Toxicon. 52: 13-21, 2008